Chapter title |
Computational Biology Methods for Characterization of Pluripotent Cells.
|
---|---|
Chapter number | 279 |
Book title |
Induced Pluripotent Stem (iPS) Cells
|
Published in |
Methods in molecular biology, July 2015
|
DOI | 10.1007/7651_2015_279 |
Pubmed ID | |
Book ISBNs |
978-1-4939-3054-8, 978-1-4939-3055-5
|
Authors |
Marcos J. Araúzo-Bravo |
Editors |
Kursad Turksen, Andras Nagy |
Abstract |
Pluripotent cells are a powerful tool for regenerative medicine and drug discovery. Several techniques have been developed to induce pluripotency, or to extract pluripotent cells from different tissues and biological fluids. However, the characterization of pluripotency requires tedious, expensive, time-consuming, and not always reliable wet-lab experiments; thus, an easy, standard quality-control protocol of pluripotency assessment remains to be established. Here to help comes the use of high-throughput techniques, and in particular, the employment of gene expression microarrays, which has become a complementary technique for cellular characterization. Research has shown that the transcriptomics comparison with an Embryonic Stem Cell (ESC) of reference is a good approach to assess the pluripotency. Under the premise that the best protocol is a computer software source code, here I propose and explain line by line a software protocol coded in R-Bioconductor for pluripotency assessment based on the comparison of transcriptomics data of pluripotent cells with an ESC of reference. I provide advice for experimental design, warning about possible pitfalls, and guides for results interpretation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 2 | 29% |
Other | 1 | 14% |
Student > Doctoral Student | 1 | 14% |
Researcher | 1 | 14% |
Professor > Associate Professor | 1 | 14% |
Other | 1 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 57% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 14% |
Economics, Econometrics and Finance | 1 | 14% |
Medicine and Dentistry | 1 | 14% |